Stents Current Events | Stents News | 4
|
|
|
Sort By:
Page Views | Date |
Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
Broncus Technologies, Inc., today announced the start of its EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational procedure that may offer a new, minimally-invasive treatment option for millions of emphysema sufferers. view more (2007-05-21)
Henry Ford Hospital to study effectiveness of a new procedure that may help emphysema suffers
Researchers at Henry Ford Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new option for those suffering with advanced emphysema. view more (2008-03-13)
ESC Congress 2003: ESC Guidelines for Percutaneous Coronary Interventions (PCI)
IMPORTANT: This press release accompanies a presentation given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology Background: The non-surgical treatment of severely narrowed coronary arteries (stenosis) has grown tremendously over... view more... (2003-09-03)
UCSF Fresno leading-edge study lends hope to emphysema patients
Patients in the Valley with emphysema might soon be breathing a little easier thanks to a new airway bypass study called the Exhale Airways Stents for Emphysema (EASE) trial. view more (2008-10-22)
ESC Congress 2003: 6 months result of a non-polymeric paclitaxel eluting stent in high-risk lesions
IMPORTANT: This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology ESC Congress 2003: Hot Line II - Acute coronary syndromes / percutaneous coronary... view more... (2003-09-01)
Study reveals embolic neuroprotection system reduces risk of cardiac events
Results of a study on the use of the FiberNet® Embolic Protection System in carotid artery stenting were reported today during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). view more (2008-10-17)
Researchers at Cedars-Sinai Medical Center to study airway bypass treatment for emphysema
Researchers at Cedars-Sinai Medical Center announced today the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a new, minimally-invasive option for those suffering with advanced widespread emphysema. view more (2007-06-07)
Bypass not to blame for heart patients' mental decline
Heart patients often experience lasting problems with memory, language, and other cognitive skills after bypass surgery. However, these problems aren't caused by the surgery itself or the pump used to replace heart function during surgery, a new study by Johns Hopkins researchers suggests. view more (2008-05-20)
Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
Researchers at Sarasota Memorial Health Care System today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. view more (2007-12-18)
New York Methodist Hospital to study airway bypass treatment for emphysema
New York Methodist Hospital today announced the start of the EASE (Exhale Airway Stents for Emphysema) Trial, an international, multi-center clinical trial to explore an investigational treatment that may offer a significant new, minimally-invasive option for those suffering with advanced widespread emphysema. view more (2008-02-05)
Modified herpes virus keeps arteries 'free-flowing' following procedures
A genetically engineered herpes simplex virus, primarily known for causing cold sores, may help keep arteries "free-flowing" in the weeks following angioplasty or stent placement for patients, according to research published early in the online edition of PNAS (Proceedings of the National Academy of Sciences of the United States of... view more... (2007-07-11)
Stanford analysis shows little difference in risk rates for angioplasty, bypass procedures
Patients with heart disease who undergo coronary angioplasty have an equivalent risk of death and heart attack as patients who undergo coronary bypass surgery, according to Stanford University School of Medicine researchers. view more (2007-10-16)
HORIZONS AMI will help set guidelines for drug and stent therapy
The HORIZONS AMI clinical trial measuring the safety and efficacy of the use of the medication bivalirudin compared to standard drug therapy - heparin and glycoprotein IIb/IIIa inhibitors -- in heart attack patients who receive angioplasty, found that after 1 year, use of bivalirudin resulted in significantly lower rates of all-cause death, death... view more... (2008-10-16)
Delayed angioplasty -- big bucks, no bang
In a subset of patients suffering heart attack, adding stents to clot-busting medical therapy after the optimal treatment window ends isn't justified, say researchers from Duke University Medical Center. view more (2007-11-06)
Natural polyester makes new sutures stronger, safer
With the help of a new type of suture based on MIT research, patients who get stitches may never need to have them removed. view more (2007-03-23)
Nanowire coating for bone implants, stents
University of Arkansas researchers have found a simple, inexpensive way to create a nanowire coating on the surface of biocompatible titanium that can be used to create more effective surfaces for hip replacement, dental reconstruction and vascular stenting. view more (2007-08-28)
Study finds coronary procedure adds no benefit over 'optimal medical therapy' alone
Percutaneous coronary intervention plus optimal medical therapy does not improve outcomes in patients with coronary artery disease, compared with optimal medical therapy alone. view more (2007-03-28)
Top 10 research advances include studies on genetics and stem cell research, stents
Several new studies on genetics and stem cell research, along with studies that continue to debate the use of stents to clear coronary artery blockages are among the top research advances in heart disease and stroke for 2007, said Daniel W. Jones, M.D., president of the American Heart Association. view more (2007-12-21)
Rutgers biomaterial debuts in clinical trials of new stent
A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials (NJCBM) at Rutgers University, has moved from the lab bench to field testing in record time. view more (2007-10-19)
Emergency bypass surgery on angioplasty patients drops 90 percent
When life-threatening problems occur during angioplasty procedures, doctors may perform emergency coronary artery bypass graft surgery, but data from the Mayo Clinic indicates that need to send patients to emergency surgery has dropped sharply. view more (2005-11-30)
|
|
|
|
Sort By:
Page Views | Date |
|
